Can elevated fecal secretory IgA indicate mucosal immune activation even when calprotectin is normal?

The claim that elevated fecal secretory IgA (sIgA) reflects mucosal immune activation due to antigen exposure or barrier dysfunction, even in the presence of normal calprotectin levels, is strongly supported by current physiological models of gut immunity. These markers represent distinct branches of the immune system: calprotectin indicates acute neutrophilic inflammation, while sIgA reflects the broader adaptive mucosal defense.

Clinical and physiological evidence

Fecal sIgA is the primary immunoglobulin of the intestinal mucosa, serving as a first-line defense against pathogens and dietary antigens. Clinical data consistently show that sIgA can rise independently of overt inflammation markers.

• Discordance with Calprotectin: Calprotectin is a highly sensitive marker for neutrophil-driven inflammation (e.g., IBD), often with a sensitivity >90% for detecting organic disease. However, patients with functional disorders like Irritable Bowel Syndrome (IBS) or food sensitivities frequently demonstrate normal calprotectin levels (<50 µg/g) alongside significantly elevated fecal sIgA.
• Antigen Response: Elevated sIgA is often observed in contexts of dysbiosis or non-celiac gluten sensitivity, where the mucosal immune system increases surveillance and neutralizing efforts without triggering a systemic or neutrophilic inflammatory cascade.

Mechanistic explanations

The elevation of sIgA in response to luminal stressors occurs through a well-defined immunological pathway:

• Immune Exclusion: When the intestinal barrier is compromised or antigen load increases, dendritic cells and M cells sample these luminal contents. This triggers B-cell class switching to IgA in the lamina propria.
• Compensatory Production: Plasma cells produce polymeric IgA, which is then transported across the epithelial cells into the lumen via the polymeric Ig receptor (pIgR). This process is a compensatory "immune exclusion" strategy designed to bind antigens and prevent them from translocating further into the body.
• Barrier Surveillance: Unlike calprotectin, which measures tissue damage and cell migration, sIgA reflects the metabolic and immunological activity of the gut-associated lymphoid tissue (GALT) as it attempts to maintain homeostasis at the barrier.

Bottom line

Elevated fecal sIgA indicates that the mucosal immune system is actively responding to luminal stressors, such as increased antigen exposure or mild barrier dysfunction. Because sIgA reflects adaptive immune surveillance rather than acute neutrophilic infiltration, it can serve as a valuable marker for low-grade immune activation in cases where standard inflammatory markers like calprotectin are normal.